Condition
Systemic Lupus Erythematous (SLE)
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07277491Completed
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
NCT07175610Not Yet RecruitingPrimary
LUpus Eritematoso Sistemico NETwork and Registry
NCT06710717Phase 1RecruitingPrimary
Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
NCT04233164Early Phase 1CompletedPrimary
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus
Showing all 4 trials